Satori Neuro invests in companies developing technologies for brain and mental health. The firm addresses multiple areas of the investment landscape to support the sector's ecosystem. It is led by Chief Investment Officer Dr. Amy Kruse, who has more than 20 years of experience in science, technology, and innovation, focused on neurotechnology and human performance. Satori's principals have experience building and managing companies. The team uses its expertise and relationships to identify businesses in the sector. Contact options include email, LinkedIn, and Twitter. The firm is associated with Satori Capital, which issues notices about unauthorized communications.
02 BY THE NUMBERS
0
EVENTS PARTICIPATED
0
ATTENDEES REACHED
0
SPEAKERS BROUGHT
0
CITIES
0 UPCOMING · 0 PAST
No events to show.
DEEP TECH WEEK · ORGANIZATIONS / SATORI-NEUROLAST INDEXED · MAY 2, 2026